Watch the newly released CBS News Global Thought Leaders video to learn more about Fresenius Kabi’s innovative approach in biosimilars to provide affordable medicines to healthcare providers and patients. Patient testimonials highlight how biosimilars have positively impacted their lives, underpinning the ongoing innovation and efforts of the Biosimilars Business Unit.

With our biosimilars, we offer alternative treatment solutions for chronic conditions and life-debilitating diseases such as cancer and autoimmune diseases. We at Fresenius Kabi can be proud to deliver these affordable options, even more though during a time when worldwide healthcare systems are under intense strain.